Local Recurrence

Trials

N

F/U (years)

No RT/No TAM

RT + TAM

Risk Reduction

NSABP B17/B24

403/899

15.0

35.1%

16.0%

54%

UK/ANZ

531/252

12.7

26.0%

8.7%

67%